Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas

Jen‐Shi Chen(Linkou Chang Gung Memorial Hospital), Chi‐Ting Liau, Hung‐Ming Wang, Wen‐Cheng Chang, Yi-Yin Jan(Chang Gung Memorial Hospital), Yung‐Chang Lin(Chang Gung Memorial Hospital)

Anti-Cancer Drugs

June 1, 1998

10.1097/00001813-199806000-00004

Cited by 43

Related Papers

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

|The Lancet|2023|1.1k

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer

|NEJM Evidence|2022|1.1k

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

|Journal of Clinical Oncology|2013|632

Intraductal papillary neoplasia of the liver associated with hepatolithiasis

|Hepatology|2001|282

Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct—an immunohistochemical study of 110 cases of hepatolithiasis

|Journal of Hepatology|2005|254